MedPath

Time-limited Specific Oral Tolerance Induction in Children With Severe Egg Allergy

Phase 1
Completed
Conditions
- Egg Hypersensitivity
Interventions
Other: Specific oral tolerance induction
Registration Number
NCT01379651
Lead Sponsor
Ospedale Buon Consiglio Fatebenefratelli
Brief Summary

To evaluate the efficacy of a 6-month specific oral tolerance induction (SOTI) protocol in inducing tolerance (maximal dose of raw egg emulsion tolerated) in children with severe IgE-mediated egg allergy and a history of at least 1 anaphylactic reaction after accidental exposure to egg.

Detailed Description

Oral immunotherapy consisted in the administration of increasing amounts of raw emulsion egg. The children started with 1 drop of undiluted raw egg emulsion (0.05 ml) flavored with vanilla and cacao, hidden by the parents in the child's breakfast (cow's milk, soymilk, fruit juice or other). The dose was doubled at intervals of about one month in the day hospital. The increases in dose were customized for each subject based on the frequency and severity of side effects, or when an inter-current illness or asthma worsening intervened during the SOTI.

The investigators limited the SOTI protocol to six months for all patients, irrespective of the dose reached, in order to favor the adherence of families to the study.

When objective symptoms seemed more important (grade 2, 3 and 4 reaction), medical treatment was given. Subjects were discontinued from the study in case of severe adverse reactions (grade 5 reaction). Parents were advised they could telephone investigators 24 hours a day

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • at least 1 anaphylactic reaction (grade 3, 4 and 5 according to Sampson's grading after accidental exposure to trace amounts of egg or egg-derivative products, requiring emergency treatment, at least 1 year before enrollment
  • demonstration of egg white specific IgE by the skin prick test (SPT), end-point SPT, raw egg white prick-by-prick (PP) and egg white-specific IgE determination
  • positive double-blind placebo-controlled food challenge (DBPCFC) at a dose of less than 0.9 ml of raw emulsion egg
Exclusion Criteria
  • age below 5 years
  • poorly controlled asthma
  • parents with a history of unreliable management of complications and treatment.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Specific oral tolerance inductionSpecific oral tolerance inductionSpecific oral tolerance induction consisted in the administration of increasing amounts of food antigen
Primary Outcome Measures
NameTimeMethod
Number of Children That Achieved Total (40 ml) or Partial (Less Than 40 ml But at Least 10 ml) Tolerance to Raw Eggbaseline and 6 months

To evaluate the efficacy of a 6-month Specific Oral Tolerance Induction (SOTI) protocol in inducing tolerance (maximal dose of raw egg emulsion tolerated after 6 months) in children with severe IgE-mediated egg allergy and a history of at least 1 anaphylactic reaction after accidental exposure to egg.

Secondary Outcome Measures
NameTimeMethod
Changes in the Median Weal Diameter, Using Egg White SPTs, End-point SPT and PPBaseline and 6 months

Before and after SOTI, we evaluated the change in the median weal diameter in millimeters, using egg white SPTs, end-point SPT and PP.

Trial Locations

Locations (1)

Unit of Pediatrics, Fatebenefratelli Hospital

🇮🇹

Benevento, Italy

© Copyright 2025. All Rights Reserved by MedPath